ATX-101 Double Chin Drug by KYTHERA FDA Approval Update 2015

KYTHERA Biopharmaceuticals, Inc. has announced on March 9, 2015 that the U.S. Food and Drug Administration’s (FDA) Dermatologic and Ophthalmic Drugs Advisory Committee has voted unanimously to support the approval of ATX-101 (deoxycholic acid) injection for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. This medical […]